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ABSTRACT 
Objective: To develop and validate novel more sensitive analytical methods for the concurrent quantification of metformin-canagliflozin and 
metformin-gliclazide in their bulk forms and in their pharmaceutical preparations. 
Methods: Two methods were developed based on several chemometric assisted spectrophotometric methods and a Reversed-Phase High-Performance 
Liquid Chromatography (RP-HPLC). The first method applies different spectrophotometric chemometric assisted methods, including ratio difference, 
derivative ratio and extended ratio subtraction method, while the second method describes a RP-HPLC separation of metformin hydrochloride-
canagliflozin and metformin hydrochloride-gliclazide binary mixtures using a C18 column with a mobile phase consisting of acetonitrile: potassium 
dihydrogen phosphate (adjusted to pH 3) with sodium lauryl sulphate as additive in the ratio of 30:70 (%v/v) in isocratic elution mode at 1 ml/min.  
Results: The proposed methods were able to quantify each of the studied drugs in their binary mixtures with high percentage recoveries in both 
methods. The spectrophotometric methods were able to quantify each of metformin, canagliflozin and gliclazide in the ranges of 2.0-20.0 μg/ml, 1.5-
40.0 μg/ml and 2.0-30.0 μg/ml, respectively. The RP-HPLC method produced well-resolved peaks at a retention time of 3.92, 6.92 and 9.10 min in 
the concentration ranges of 50.0-300.0 μg/ml, 5.0-50.0 μg/ml and 10.0-100.0 μg/ml for metformin, canagliflozin and gliclazide, respectively. The 
proposed methods were optimized and validated in accordance to the International Conference of Harmonisation (ICH) guidelines in terms of 
linearity, LOD, LOQ, precision and accuracy. 
Conclusion: The developed methods were found to be sensitive and reproducible methods for the simultaneous determination of anti-diabetic 
binary mixtures; metformin hydrochloride-canagliflozin and metformin hydrochloride-gliclazide. And thus were successfully employed for the 
quality control analysis of the pharmaceutical formulations of the studied binary mixtures.  
Department of Pharmaceutical Technology, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon 
Email: malak.albathish@gmail.com 
Keywords: Binary mixtures, Metformin-Canagliflozin, Metformin-Gliclazide, Spectrophotometric chemometric assisted methods, RP-HPLC 
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open-access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
DOI: http://dx.doi.org/10.22159/ijpps.2020v12i2.35415.  Journal homepage: https://innovareacademics.in/journals/index.php/ijpps 
 
INTRODUCTION 
Diabetes is a lifelong progressive disease characterized by high 
levels of blood glucose [1]. Currently, metformin is being used as 
first-line therapy in the treatment of diabetes mellitus type 2. 
However, for most patients, glycemic control is not sufficiently 
established by this monotherapy, leading to the requirement for 
combination therapy
Metformin (MTF) is official in both the British Pharmacopeia (BP) [2] 
and United State Pharmacopeia (USP) [3], gliclazide (GLIC) is official in 
the BP, whereas Canagliflozin (CANA) is still a novel drug in the market, 
and no official method is yet available in any pharmacopoeia. 
. Metformin hydrochloride-Canagliflozin is a 
recently introduced co-formulation in the market whereas 
metformin hydrochloride-gliclazide is one of the most used co-
formulation in the current practice. 
Literature survey has revealed that each of the metformin 
hydrochloride, canagliflozin and gliclazide were determined 
individually as a single component in bulk, pharmaceutical 
formulations and biological fluids by several analytical methods. 
Metformin hydrochloride has been determined simultaneously with 
canagliflozin using RP-HPLC [4-7] and spectrophotometry [8]. In 
presence of gliclazide, metformin hydrochloride has been 
determined by High Performance Thin Layer Chromatography 
(HPTLC) [9, 10], Liquid Chromatography-Mass Spectrometry (LC-
MS) [11, 12], spectrophotometric methods [13-17], and HPLC with 
Ultra-violet (UV) detection [18-26]. 
  
 
Fig. 1: Structures of (A) Metformin Hydrochloride, (B) Canagliflozin, (C) Gliclazide 
 
Spectrophotometric methods present a good option in the analysis 
of multicomponent pharmaceutical mixtures based on the 
availability, simplicity and low cost. Classical UV spectral 
measurement use is often limited due to the overlapping of spectral 
peaks unless prior separation and extraction are employed. Several 
UV spectrophotometric chemometric methods are used in the 
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simultaneous analysis for resolving mixtures based on mathematical 
processing and manipulations of the absorption spectra [27-34], 
offering sometimes an alternative to chromatographic methods.  
This work aims to evolve new, yet more sensitive methods for 
concurrent quantification of MTF-CANA and MTF-GLIC in their bulk 
forms and in their pharmaceutical preparations. The idea for the 
comparative study using two different techniques has emerged from the 
need to find the most suitable analytical method in short time to be 
applicable in quality control labs giving the analyst the choice of the 
preferable detector based on its availability. The methods are based on 
several chemometric methods [27] including ratio difference, derivative 
ratio, and extended ratio subtraction methods, also a RP-HPLC. Methods 
have been developed and followed by full validation for each method.  
MATERIALS AND METHODS 
Chemicals and materials  
Metformin hydrochloride was certified to contain 99.7% (Merck Sante, 
France), Canagliflozin was certified to contain 99.8% (Janssen Cilag, 
USA), and Gliclazide was certified to contain 99.3% (Servier, France). 
Vokanamet® tablets (Janssen Cilag, USA), labelled to contain 850 mg 
metformin hydrochloride and 50 mg canagliflozin. Orbizide M 
Forte® tablets (Pharmaline, Lebanon) labelled to contain 500 mg 
metformin hydrochloride and 40 mg gliclazide. 
All chemicals and solvents used were of HPLC grade; Methanol 
(SIGMA-ALDRICH, CHROMASOLV® FOR HPLC), acetonitrile 
(SIGMAALDRICH CHROMASOLV®FOR HPLC>99.9%), KH2PO4
Instrumentation 
 
(Merck KGaA), deionized water was produced in-house. 
Jasco V-730 double beam UV-Vis Spectrophotometer interfaced to a 
computer programmed with Jasco Spectra Manager software was 
used for spectrophotometric measurements, spectral acquisition 
and elaboration. A pair of 1 cm quartz cells were used to measure 
the absorption spectra.  
The RP-HPLC separation was performed on an HPLC system; Jasco 
PU-2089 series (Japan) equipped with quaternary pump, diode 
array detector, and a manual injector which uses a Rheodyne port 
sample injection valve fitted with 20 µl sample loop. Liquid 
separations are performed on Lichrospher 100 RP C18 
Preparation of standard stock solutions 
analytical 
column (250 mm x 4.6 mm x 5μm). A Glassco diaphragm Vacuuum 
pump was used to degas and filter the mobile phase by passing 
through 0.5 μm pore size membrane filter at a pumping speed of 30 
L/min. A 0.2 μm Minisart SRP 15 (Sartorius Stedim) syringe driven 
disposable filters was used to filter the samples. 
Stock solutions of MTF, CANA and GLIC standards having the 
concentrations of 1000 µg/ml, 1000 µg/ml, and 600 µg/ml, 
respectively, were prepared using methanol as a solvent. 
Chemometric assisted spectrophotometric methods  
Preparation of working standard solutions 
Aliquots of the standard stock solutions of each drug were 
separately diluted with methanol to obtain working standard 
solutions having the concentrations of 200 µg/ml for MTF, 100 
µg/ml for CANA and 60 µg/ml for GLIC. 
Calibration graphs  
Calibration graphs were prepared from these working standard 
solutions by diluting with methanol to achieve the concentration 
range of 2-20 µg/ml for MTF, 1.5-40 µg/ml for CANA and 2-30 
µg/ml for GLIC. The absorption spectra were recorded at 1-nm 
interval in the range of 200-300 nm for GLIC and 200-400 nm for 
MTF and CANA, against methanol as blank.  
Synthetic mixtures  
Aliquots of the working standard solutions of MTF and CANA or MTF 
and GLIC were transferred into a series of 10-ml volumetric flasks 
and completed to volume with methanol to give synthetic mixtures 
containing 20:5 µg/ml and 15:2.5 µg/ml, respectively. The 
absorption spectrum for each mixture was recorded at 1-nm interval 
in the range of 200-400 nm against methanol as blank and then 
analysed by the developed method to assay the quantity of both 
MTF-CANA, or MTF-GLIC in the synthetic mixtures. 
RP-HPLC method  
Chromatographic conditions  
The chromatographic analysis was performed with isocratic elution 
using C18 column at a detection wavelength of 229 nm. The mobile 
phase used for the chromatographic separation was prepared by 
adding HPLC grade acetonitrile to the aqueous phase in the ratio of 
30:70 %v/v. The mobile phase was pumped through the column at a 
flow rate of 1 ml/min and injection volume of 20 µl. Separation was 
carried out at ambient temperature. 
The aqueous phase was prepared by weighing 1.36 g of potassium 
dihydrogen phosphate (KH2PO4
Calibration graphs  
) and 2.88 g of sodium lauryl 
sulphate and dissolving them in 1 L HPLC grade water, then 
adjusting its pH to a value of 3 with orthophosphoric acid. 
The mobile phase was filtered and degassed for 30 min using an 
ultrasonic sonicator. 
Calibration graphs were prepared from the standard stock solutions 
by diluting with methanol to achieve the concentration range of 50-
300 µg/ml for MTF, 5-50 µg/ml for CANA and 10-100 µg/ml for 
GLIC. The above solutions were filtered and 20 µl portion of these 
solutions were injected and chromatographed. The standard 
calibration graphs were prepared by plotting the peak area values of 
each drug against the corresponding concentrations. 
Synthetic mixtures  
Aliquots of standard stock solutions of MTF, CANA or GLIC were 
transferred into a series of 10-ml volumetric flasks and completed to 
volume with methanol to give synthetic mixtures in the ratios stated in 
table 7. The above solutions were filtered and 20 µl portion of these 
solutions were injected in triplicates on three different days and 
chromatographed. The peak areas for each drug were used to acquire 
the corresponding concentration by referring to its calibration graph.  
Pharmaceutical application 
Ten tablets of Orbizide® or Vokanamet®
Method validation 
 were accurately weighed 
and finely powdered. Powder amount equivalent to one tablet of 
each, was accurately weighed, transferred to a 100-mL volumetric 
flask and diluted to volume with HPLC grade methanol. The obtained 
solutions were then filtered using Whatmann No. 41 filter paper. An 
appropriate volume of these solutions was transferred to 10-ml 
volumetric flask, diluted to the mark with the same solvent. 
The absorption spectra of the obtained solutions were recorded at 1-
nm interval in the range of 200-400 nm against methanol as a blank 
and then analyzed by the developed chemometric assisted 
spectrophotometric methods to assay the quantity of each drug in 
their co-formulated pharmaceutical tablets. 
In RP-HPLC method, the solutions were filtered and 20 µl portion of 
these solutions were injected in five replicates and chromatographed. 
The peak areas for each drug were used to acquire the corresponding 
concentration by referring to its calibration graph. 
Under the optimized experimental conditions, the developed methods 
were validated according to the procedures described in ICH 
guidelines for the following parameters: Linearity, limit of detection 
(LOD), limit of quantitation (LOQ), precision and accuracy [35]. 
Linearity, concentration range, limit of detection and limit of 
quantitation  
Linearity was determined in the concentration range of 2-20 µg/ml 
for MTF, 1.5-40 µg/ml for CANA and 2-30 µg/ml for GLIC for the 
chemometric assisted spectrophotometric methods, and 50-300 
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µg/ml for MTF, 5-50 µg/ml for CANA and 10-100 µg/ml for GLIC for 
the RP-HPLC method. The amount of MTF, CANA and GLIC present in 
the sample was computed from the corresponding calibration curve. 
LOD and LOQ were calculated according to the ICH guidelines by 









Accuracy and precision  
” is the standard deviation of the regression 
line/residuals and “b” is the slope of the calibration curve. 
In order to assess the accuracy and precision of the proposed 
methods, standard solutions containing MTF, GLIC or CANA and 
synthetic mixtures with different ratios of MTF-CANA and MTF-GLIC 
were analysed. The precision of the proposed methods was assessed 
by intra-day and inter-day variation studies using three 
concentrations of each for five times. During intra-day studies, five 
sample solutions of each concentration were analysed on the same 
day whereas inter-day studies were determined by analysing five 
sample solutions of each concentration for three consecutive days. 
The accuracy of the proposed methods was assessed by analysing 
synthetic mixtures with different ratios. Afterwards, the mean 
percentage recovery and percentage relative standard deviation 
were calculated.  
RESULTS AND DISCUSSION 
Chemometric assisted spectrophotometric methods 
The spectral overlapping between the absorption spectra of MTF 
and CANA (fig. 2) or MTF and GLIC (fig. 3) exhibit significant 
interference imposed by each drug while determining the other 
which limits the use of conventional UV spectrophotometry for their 
simultaneous determination. Therefore, simultaneous determination 
of these drugs in binary mixture or in co-formulated pharmaceutical 
formulations requires mathematical manipulation of the absorption 
data to omit the interference. Accordingly, three simple 
spectrophotometric methods; namely ratio difference, derivative 
ratio, and extended ratio subtraction methods were developed for 




Fig. 2: Overlain absorption spectra of MTF (16 µg/ml), CANA (5µg/ml) and their binary mixture 
 
 
Fig. 3: Overlain absorption spectra of MTF (15 µg/ml), GLIC (3.5µg/ml) and their binary mixture 
 
Ratio difference (ΔP)  
As shown in fig. 2 and fig. 3, the absorption spectra of the binary 
mixtures composed of MTF-CANA or MTF-GLIC show high degree of 
overlap. So, to overcome this mutual interference, the absorbance 
ratio; a one-step correction method was adopted. 
For method optimization, two factors were considered: the effect of 
divisor concentration for each drug and the choice of the 
wavelength. Selection was based on minimum noise, maximum 
sensitivity, high accuracy and precision. When the concentration of 
the divisor was varied, the ratio spectra proportionally varied with 
no change in the position of the peaks and troughs [27, 29].  
MTF was determined in MTF-CANA binary mixture, where the 
recorded spectra of standard MTF solutions and that of its mixtures 
with CANA were divided by the absorption spectrum of CANA having 
the concentration of 2 µg/ml. The ratio spectra of different MTF 
standard solutions were obtained. The peak to trough amplitudes 
between 233-211 nm on the established ratio spectra were 
proportional to MTF concentration. Consequently, the regression 
equation was derived (fig. 4). 
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Fig. 4: Ratio spectra of MTF (16 µg/ml), CANA (5µg/ml) and their binary mixture where the divisor is CANA (2µg/ml) 
 
CANA was determined in MTF-CANA binary mixture, where the 
recorded spectra of standard CANA solutions and that of its mixtures 
with MTF were divided by the absorption spectrum of MTF having 
the concentration of 18 µg/ml. The ratio spectra of different CANA 
standard solutions were obtained. The peak to trough amplitudes 
between 278-295 nm on the established ratio spectra were 
proportional to CANA concentration. Consequently, the regression 
equation was derived (fig. 5). 
 
 
Fig. 5: Ratio spectra of MTF (16 µg/ml), CANA (5µg/ml) and their binary mixture where the divisor is MTF (18µg/ml) 
 
MTF was determined in MTF-GLIC binary mixture, where the 
recorded spectra of standard MTF solutions and that of its mixtures 
with GLIC were divided by the absorption spectrum of GLIC having 
the concentration of 4.5µg/ml. The ratio spectra of different MTF 
standard solutions were obtained. The peak to trough amplitudes 
between 248-222 nm on the established ratio spectra were 
proportional to MTF concentration. Consequently, the regression 
equation was derived (fig. 6). 
  
 
Fig. 6: Ratio spectra of MTF (15 µg/ml), GLIC (3.5µg/ml) and their binary mixture where the divisor is GLIC (4.5 µg/ml) 
 
GLIC was determined in MTF-GLIC binary mixture, where the 
recorded spectra of standard GLIC solutions and that of its mixtures 
with MTF were divided by the absorption spectrum of MTF having 
the concentration of 18 µg/ml. The ratio spectra of different GLIC 
standard solutions were obtained. The peak to trough amplitudes 
between 223-248 nm on the established ratio spectra were 
proportional to GLIC concentration. Consequently, the regression 
equation was derived (fig. 7). 
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Fig. 7: Ratio spectra of MTF (15 µg/ml), GLIC (3.5µg/ml) and their binary mixture where the divisor is MTF (18 µg/ml) 
 
First derivative ratio D1R  
In this method, two parameters were studied and optimized to 
obtain good selectivity and high sensitivity: wavelength interval (Δλ) 
and divisor concentration [27, 31-33].  
The influence of Δλ was investigated to obtain the optimum 
wavelength intervals in terms of maximum resolution and 
sensitivity whereby the Δλ value affects the shape and the position 
of the peaks to be analysed as well as the zero-crossing point of the 
other component in the mixture. The D1 curves were traced at 8 nm 
interval for MTF-CANA and at 6 nm for MTF-GLIC, where other Δλ 
values gave poor resolution. 
The concentration of MTF was determined at 244 nm for both 
binary mixtures in the corresponding D1 curves obtained from the 
ratio spectra where the divisors were CANA (2 µg/ml) and GLIC 
(4.5 µg/ml), respectively. The concentration in the mixture was 
derived from the calibration curve of the D1R of standard MTF (fig. 
8 and fig. 9). 
 
 
Fig. 8: D1 of the ratio spectra of MTF (16 µg/ml), CANA (5µg/ml) and their binary mixture where the divisor is CANA (2µg/ml) 
 
 
Fig. 9: D1 of the ratio spectra of MTF (15 µg/ml), GLIC (3.5µg/ml) and their binary mixture where the divisor is GLIC (4.5 µg/ml) 
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The concentration of CANA was determined at 320 nm in MTF-CANA 
binary mixture in the corresponding D1 curves obtained from the 
ratio spectra where the divisor was MTF (18 µg/ml). The 
concentration in the mixture was derived from the calibration curve 
of the D1R of standard CANA (fig. 10). 
The concentration of GLIC was determined at 240 nm in MTF-GLIC 
binary mixture in the corresponding D1 curves obtained from the 
ratio spectra where the divisor was MTF (18 µg/ml). The 
concentration in the mixture was derived from the calibration curve 
of the D1R of standard GLIC (fig. 11). 
 
 
Fig. 10: D1 of the ratio spectra of MTF (16 µg/ml), CANA (5µg/ml) and their binary mixture where the divisor is MTF (18µg/ml) 
 
 
Fig. 11-D1 of the Ratio spectra of MTF (15 µg/ml), GLIC (3.5µg/ml) and their binary mixture where the divisor is MTF (18 µg/ml) 
 
Extended ratio subtraction method (EXRSM)  
The proposed method is based on that MTF has a more extended 
spectrum than CANA and GLIC as shown in fig. 2 and fig. 3. 
This method begins by applying the Ratio subtraction method 
(RSM). It is done by dividing the zero order absorption spectra of the 
studied mixtures (A) by an absorption spectrum of carefully chosen 
concentration (A °). Different concentrations of CANA and GLIC were 
tested, it was found that 2 µg/ml CANA or 4.5 µg/ml GLIC gave 
minimum noise, smoother ratio spectra and maximum sensitivity. 
Dividing the mixture absorption spectra by 2 µg/ml standard CANA 
or 4.5 µg/ml standard GLIC, produces new spectra, that represent 
(ACANA/ACANA °+ACANA/ACANA °) or (AGLIC/AGLIC °+AMTF/AGLIC °), where 
(ACANA/ACANA °) or (AGLIC/AGLIC °) have constant values. Then, 
subtraction of these constant values in the plateau region (270-300 
nm) in MTF-CANA binary mixture or (265-280 nm) in MTF-GLIC 
binary mixture, followed by multiplication of the obtained spectra by 
the divisor spectrum, the original absorption spectrum of MTF is 
obtained and can be used directly for MTF determination at 237 nm 
from the corresponding regression equation [27,34]. 
(AMTF+ACANA)/ACANA ° 
AMTF/ACANA °+ACANA/ACANA ° = AMTF/ACANA °+constant.  
AMTF/ACANA °+constant-constant  
AMTF/ACANA ° * ACANA ° 
AMTF 
(AMTF+AGLIC)/AGLIC ° 
AMTF/AGLIC °+AGLIC/AGLIC ° = AMTF/AGLIC °+constant.  
AMTF/AGLIC °+constant-constant  
AMTF/AGLIC ° * AGLIC ° 
AMTF 
The determination of CANA or GLIC could be done by the EXRSM. The 
spectrum of MTF obtained from the RSM method and the absorption 
spectra of the mixtures, are divided by the absorption spectrum of 
standard MTF having the concentration of 18 µg/ml; producing a new 
spectrum that represents (ACANA/AMTF °+ACANA/AMTF °) or (AGLIC/AMTF 
°+AMTF/AMTF °) and the constant (AMTF/AMTF °) in the plateau region 
(210-250 nm). Subtracting the above produced constant spectrum 
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(AMTF/AMTF °) from (ACANA/AMTF °+ACANA/AMTF °) or (AGLIC/AMTF 
°+AMTF/AMTF °) followed by multiplication by the divisor AMET °, will 
generate new spectra. These spectra could be used for the direct 
determination of CANA at 290 nm and GLIC at 228 nm and calculate 
their concentrations from the corresponding regression equation.  
(AMTF+ACANA)/AMTF ° 
AMTF/AMTF °+ACANA/AMTF ° = ACANA/AMTF °+constant.  
ACANA/AMTF °+constant-constant  
ACANA/AMTF ° * AMTF ° 
ACANA 
(AMTF+AGLIC)/AMTF ° 
AMTF/AMTF °+AGLIC/AMTF ° = AGLIC/AMTF °+constant.  
AGLIC/AMTF °+constant-constant  
AGLIC/AMTF ° * AMTF ° 
AGLIC 
RP-HPLC method 
RP-HPLC method was developed to provide an adequate method for 
the simultaneous determination of MTF-CANA and MTF-GLIC in the 
synthetic mixtures and in pharmaceutical formulations. The most 
important attribute is to achieve sufficient resolution with 
acceptable peak symmetry in a RP-HPLC method at reasonable time. 
So, preliminary investigations aimed to maximize the resolution and 
sensitivity of the method. The parameters were assessed and 
optimized as stated in Table 1. 
Several mobile phases were tried using various ratios of different 
aqueous and organic modifiers. The best separation was obtained 
using a mobile phase composed of acetonitrile: phosphate buffer 
(70:30 %v/v) at pH 3 with 0.01 M sodium lauryl sulfate. Separation 
was done at wavelength of 229 nm and at a flow rate of 1 ml/min. 
Fig. 12 and 13, show the separation of MTF at 3.9 min, CANA at 9.1 
min, and GLIC at 6.9 min. 
 
Table 1: Optimized chromatographic conditions for the separation of MTF-CANA and MTF-GLIC 
Parameter Condition 
Mobile Phase Acetonitrile: phosphate buffer (70:30) at pH 3 with 0.01 M sodium lauryl sulfate 
Stationary Phase C18 column (250 mm x 4.6 mm x 5μm) 
Flow rate (ml/min) 1 
Run time (min) 10 
Volume of injection (μl) 20 
Detection wavelength (nm) 229 
 
Table 2: HPLC system suitability parameters for the determination of MTF-CANA and MTF-GLIC using the proposed method 












Metformin 3.92 1.04 --- 2230 1.407 --- 
Canagliflozin 6.917 2.60 5.5 3265 1.303 2.5 
Gliclazide 9.10 3.74 12.3 3702 1.244 3.60 
 
 
Fig. 12: HPLC chromatogram of a 20 µl injection of a standard mixture of 250 µg/ml MTF and 50 µg/ml CANA using the optimized 
chromatographic conditions 
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Fig. 13: HPLC chromatogram of a 20 µl injection of a standard mixture of 250 µg/ml MTF and 40 µg/ml GLIC using the optimized 
chromatographic conditions 
 
Table 3: Assay parameters for the determination of MTF-CANA and MTF-GLIC in presence of each other using the applied 
spectrophotometric methods 
Metformin 
Parameters A ΔP D1R 
Conc. Range (µg/ml) 2.0-20.0 
λ or λ range(nm) 237 228 248-222 233-211 244 244 
Δλ (nm)     6 8 
r 0.9993 0.9993 0.9993 0.9994 0.9996 0.9989 
S y/x 0.0149 0.0119 0.29543 2.68213 0.02027 0.23625 
a (intercept) 0.0262 -0.002 0.19663 1.14748 0.02569 -0.16933 
b (slope) 0.0905 0.0687 2.13804 15.4521 0.18266 -1.02883 
Sa 0.0103 0.0083 0.31418 1.65844 0.02156 0.13769 
Sb 0.0008 0.0007 0.02279 0.13509 0.00156 0.01162 
LOD (µg/ml) 0.54 0.57 0.46 0.57 0.37 0.76 
LOQ (µg/ml) 1.65 1.73 1.38 1.74 1.11 2.30 
Gliclazide 
Parameters A ΔP D1R 
Conc. Range (µg/ml) 2.0-30.0 
λ or λ range(nm) 228 237 223-248 240 
Δλ (nm)     
r 0.9998 0.9983 0.9997 0.9996 
S y/x 0.00732 0.00407 0.00711 0.00046 
a (intercept) -0.00717 -0.00537 -0.00092 0.00069 
b (slope) 0.04354 0.02551 0.03703 -0.00204 
Sa 0.00456 0.00253 0.00381 0.00025 
Sb 0.00027 0.00015 0.00024 0.00002 
LOD (µg/ml) 0.55 0.53 0.63 0.75 
LOQ (µg/ml) 1.68 1.60 1.92 2.28 
Canagliflozin 
Parameters A ΔP D1R 
Conc. Range (µg/ml) 1.5-40.0 
λ or λ range(nm) 290 237 278-295 320 
Δλ (nm)    8 
r 0.9999 0.9987 0.9998 0.9999 
S y/x 0.00560 0.00564 0.71436 0.01384 
a (intercept) 0.00169 -0.00858 -0.70414 0.02059 
b (slope) 0.04180 0.00958 -2.96632 0.36026 
Sa 0.00317 0.00320 0.31916 0.00618 
Sb 0.00015 0.00015 0.01739 0.00034 
LOD (µg/ml) 0.44 1.94 0.79 0.13 
LOQ (µg/ml) 1.34 5.89 2.41 0.38 
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Table 4: Assay parameters for the determination of MTF, GLIC and CANA using the proposed RP-HPLC method 
Parameter MTF GLIC CANA 
Concentration range (µg/ml) 50-300 10-100 5-50 
Regression equation    
Intercept (a) -1680665.31  -102139  44163.13  
Slope (b) 99378.45  39954.37  15229.25  
Correlation coefficient (r) 0.998 0.999 0.999 
Sa 459559.95 33158.89 1645.24 
Sb 2360.08 484.32 55.82 
Sy/x 493646.57 27074.12 1966.22 
LOD (µg/ml) 16.39 2.24 0.43 
LOQ (µg/ml) 49.67 6.78 1.29 
 
System suitability 
In accordance to Food and Drug Administration (FDA) guidance, 
system suitability tests are of the essentials in any liquid 
chromatographic method [36]. Under the optimized 
chromatographic conditions, system suitability parameters 
including capacity factor (k’), resolution (Rs), column efficiency (N), 
tailing factor (T), repeatability in terms of Relative Standard 
Deviation (RSD), and selectivity (α) were performed and listed in 
table 2. All were satisfactory pointing out the selectivity and 
efficiency of the method for separation of the binary mixtures MTF-
CANA and MTF-GLIC. 
Method validation 
Under the optimized experimental conditions, the developed 
methods were validated according to the procedures described in 
ICH guidelines [35]. 
Linearity, concentration range, limit of detection and limit of 
quantitation  
Under the described experimental conditions, linearity was 
established over the concentration ranges stated in Tables 3 and 4; 
the graphs were obtained by plotting the ratio difference (ΔP), and 
D1 of the ratio spectra or the peak area each versus concentration of 
MTF, CANA or GLIC in case of chemometric methods and RP-HPLC 
method, respectively. 
The values of the correlation coefficient (r), intercept (a), slope (b) and 
standard deviation of residuals (Sy/x) showed good linearity of the 
calibration graphs and the conformity with Beer’s law. The low LOD 
and LOQ values obtained confirm the sensitivity of the proposed 
methods (tables 3 and 4). 
Accuracy and precision  
The percentage recoveries were obtained for each mixture by 
applying the ΔP, D1R, RSM and RP-HPLC methods (Tables 5, 6 and 7). 
The spectral interferences in the determination of MTF-CANA or 
MTF-GLIC in the presence of each other using the proposed methods 
were corrected. Good percentage recoveries were obtained. These 
applied methods indicate their potential for correction of spectral 
interferences in the determination of MTF-CANA and MTF-GLIC 
binary mixtures. 
 
Table 5: Intra-day and inter-day precision for the simultaneous determination of MTF-CANA, and MTF-GLIC in presence of each other in 
synthetic mixture using the proposed spectrophotometric methods 
Analytical Method MTF: GLIC 
µg/ml 
Intra-day precision, mean recovery±SD 
%RSD, %error 
Inter-day precision, mean recovery±SD 
%RSD, %error 
MTF GLIC MTF GLIC 




































Analytical Method MTF: CANA 
µg/ml 
Intra-day precision, mean recovery±SD 
%RSD, %error 
Inter-day precision, mean recovery±SD 
%RSD, %error 
MTF CANA MTF CANA 




































mean±SD for five determinations, Relative standard deviation, Relative error 
 
Method application 
The validated spectrophotometric chemometric and RP-HPLC 
methods were successfully applied for the determination of the binary 
mixtures MTF-CANA and MTF-GLIC in their pharmaceutical 
formulations OrbizideP®P and VokanametP®P. High percentage recoveries 
were obtained with low % RSD which indicate high accuracy and 
precision in the determination of the studied mixtures in their 
commercial tablets without the interference of the common excipients 
in the determination. The results obtained are summarized in table 8 
and compared statistically by means of Student’s t-test for accuracy 
and F-test for precision at 95% confidence level. 
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Table 6: System accuracy and precision data for the determination of MTF, GLIC and CANA using the proposed RP-HPLC method 
 tR Amount taken(µg/ml) Amount found(µg/ml) a% RSD b% Recovery 
MTF 3.92±0.02 100 98.82 1.24 98.82 
200 198.46 1.07 99.23 
250 245.38 0.44 98.15 
GLIC 9.10±0.33 25 25.05 1.22 100.20 
40 40.03 0.90 100.07 
100 100.42 0.40 100.42 
CANA 6.917±0.12 5 4.93 1.33 98.60 
10 10.12 1.1 101.20 
50 49.99 1.73 99.98 
aRelative standard deviation, b
Mixture 
Mean for five determinations 
 
Table 7: Accuracy and precision data for the simultaneous determination of MTF-GLIC and MTF-CANA in synthetic mixtures using the 
proposed RP-HPLC method 
Nominal value (µg/ml) Statistic parameters, aMean recovery±SD, b%RSD, c%Error 
Inter-day Intra-day 
MTF: GLIC MTF GLIC MTF GLIC MTF GLIC 




































MTF: CANA MTF CANA MTF CANA MTF CANA 




































amean±SD for three determinations, bRelative standard deviation, c
 
Table 8: Assay results for MTF-GLIC, and MTF-CANA in commercial tablets using the proposed spectrophotometric methods 
Relative error 
 Drug aMean recovery±SD, b%RSD, c%Error 

























































































amean±SD for five determinations, bRelative standard deviation, cRelative error, **
 
Theoretical values of t-and F-test at P=0.05 are 2.13 and 5.05 
respectively 
CONCLUSION 
In conclusion, the present work represents an approach for the 
assay of the MTF-CANA and MTF-GLIC antidiabetic binary mixtures. 
The developed chemometric methods depend on the absorption 
spectra of the drugs. The use of ratio spectra can magnify the 
prediction ability of the usual spectrophotometric techniques, where 
the treatment of absorbance ratio generates signals for the mixtures 
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depending only on one analyte and eliminating the interfering effect 
of other analytes in the mixture. Such methods are considered as 
highly sensitive, low cost green analytical techniques, where most of 
the work is done in front of the computer, thus it applies neither 
sophisticated instrument nor prior separation steps. Accordingly, 
such methods can be employed for the quality control of these drugs 
in pharmaceutical companies. Although the developed RP-HPLC is 
not more sensitive than the applied chemometric methods, but it can 
give an advantage for future plans for the analysis of the same 
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